Reducing and capping agent; acetylcholinesterase and Butyrylcholinesterase inhibitory activities; excellent free radical scavenging and metal chelating activity, suitable for Alzheimer’s disease therapy. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.